Evidence map›Paper›PMID 34840647›Full record

ArticleThe Journal of clinical and aesthetic dermatology2021

Limiting Residency Applications to Dermatology Benefits Nearly Everyone.

Aaron M Secrest, Garrett C Coman, J Michael Swink, Keith L Duffy

Abstract readEditorial
In one paragraph

Article in The Journal of clinical and aesthetic dermatology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. A Eulogy for the Match.Journal of graduate medical education · 2023
    Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Aaron M SecrestDrs. Secrest, Coman, and Duffy are with the Department of Dermatology at the University of Utah in Salt Lake City, Utah.
Garrett C ComanDrs. Secrest, Coman, and Duffy are with the Department of Dermatology at the University of Utah in Salt Lake City, Utah.
J Michael SwinkDrs. Secrest, Coman, and Duffy are with the Department of Dermatology at the University of Utah in Salt Lake City, Utah.
Keith L DuffyDrs. Secrest, Coman, and Duffy are with the Department of Dermatology at the University of Utah in Salt Lake City, Utah.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

With a 34-percent increase in dermatology residency applications in the past decade, residency programs are increasingly faced with the daunting task of reviewing more applications for a relatively fixed number of residency positions. Other specialty programs, including otolaryngology, orthopedics, plastic surgery, and ophthalmology, have called for limiting the number of residency applications. Dermatology programs have developed various ways to decrease the number of reviewed applications, from cutoffs for Step 1 board scores to Alpha Omega Alpha membership to secondary applications. While this can decrease the applicant pool, it limits a more holistic review of applications. We propose an application cap of 20 programs, which will decrease the number of applications each program receives 3- to 5-fold. Each applicant can approach the process more thoughtfully in choosing the best programs for them and will save money in application fees. As program directors rank "perceived interest" in their residency program as a primary factor for selecting applicants, a cap will allow program directors to know that all applicants are interested in their specific program. Ultimately, we contend that application caps would improve match outcomes with applicants receiving training in the best program for them, increasing the likelihood of successful fit for clinical training, opening the field to a more diverse set of applicants, and saving everyone time and money.

Indexed as

COVIDDermatologyequityERASgame theoryNRMPresidency applicationsselection processStep 1 exam

Identifiers

PMID34840647
PMCPMC8570359

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.